市場調査レポート
商品コード
1291558
電子データキャプチャシステム市場:配信モード別、コンポーネント別、開発段階別、エンドユーザー別、地域別2023-2028Electronic Data Capture Systems Market by Delivery Mode, Component, Development Phase, End User, and Region 2023-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
電子データキャプチャシステム市場:配信モード別、コンポーネント別、開発段階別、エンドユーザー別、地域別2023-2028 |
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2~3営業日
|
世界の電子データキャプチャ(EDC)システムの市場規模は、2022年に11億3,000万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に11.70%の成長率(CAGR)を示し、2028年までに23億米ドルに達すると予測しています。臨床試験の急速なデジタル化、クラウドベースのシステム採用の増加、モバイルEDCの導入などが、市場を牽引する主な要因の一つです。
電子データキャプチャ(EDC)システムとは、臨床試験データを電子形式で収集・管理するために設計されたソフトウェアツールのことを指します。患者の属性、病歴、有害事象、検査結果、臨床結果評価、電子インフォームド・コンセント(eConsent)、治験施設情報など、さまざまなデータを取得することができます。EDCシステムは、規制当局、治験依頼者、委託研究機関(CRO)、治験参加者、データ管理者によって広く使用されています。EDCシステムは、データ収集の合理化、データ品質の向上、ヒューマンエラーの最小化、機密情報の保護、データ損失や重複のリスクの低減に役立ちます。また、EDCシステムは、臨床試験の効率を高め、リアルタイムのモニタリング機能を提供し、意思決定を支援し、データの正確性、信頼性、一貫性を保証します。
世界中で臨床試験が急速にデジタル化されていることが、市場成長を促進する主要因の1つです。EDCシステムは、データの収集、保存、モニタリング、分析など、さまざまな臨床試験業務の自動化に広く利用されており、その結果、プロセスの迅速化、透明性の確保、エラーの防止、全体的な効率の向上が実現します。さらに、糖尿病、高血圧、アルツハイマー病、多発性硬化症、心血管疾患(CVD)などの慢性疾患の増加による新しい治療法や治療薬への需要の高まりも、成長を促す要因として作用しています。さらに、費用対効果に優れ、ユーザーフレンドリーで拡張性が高く、安全性が高く、データにリアルタイムでアクセスできるクラウドベースのシステムの採用が増加していることも、市場の成長に拍車をかけています。また、スマートフォンやタブレットを利用したモバイルEDCは、患者のデータを収集するための便利で費用対効果の高い方法であるため、エンゲージメントの向上、コンプライアンスの向上、エラーのリスクの低減につながり、市場成長に好影響を及ぼしています。これとは別に、機械学習(ML)と人工知能(AI)を統合してデータ分析を改善し、迅速な意思決定を可能にし、パターン、動向、異常を特定することは、市場の成長にプラスの影響を与えています。さらに、臨床試験データの安全性と完全性に関する厳格な政府規制の導入は、当局へのコンプライアンス強化を支援するEDCなどの高度なデータ管理および報告システムの需要を促進しています。その他の要因として、個別化された医薬品に対する需要の増加、広範な研究開発活動、患者中心の臨床試験への注目の高まりが、市場の成長を促進すると予想されています。
これは企業の一部のリストのみを示しており、完全なリストはレポートに記載されていることに注意してくださいです。
The global electronic data capture (EDC) systems market size reached US$ 1.13 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.3 Billion by 2028, exhibiting a growth rate (CAGR) of 11.70% during 2023-2028. The rapid digitalization of clinical trials, the rising adoption of the cloud-based system, and the introduction of mobile-EDC represent some of the key factors driving the market.
Electronic data capture (EDC) systems refer to software tools designed to collect and manage clinical trial data in electronic format. They capture a wide variety of data, including patient demographics, medical history, adverse events, laboratory results, clinical outcome assessments, electronic informed consent (eConsent), and study site information. EDC systems are widely used by regulatory agencies, clinical trial sponsors, contract research organizations (CROs), trial participants, and data managers. They help streamline data collection, improve data quality, minimize human errors, protect sensitive information, and reduce the risk of data loss and duplications. EDC systems also enhance the efficiency of the clinical trial, provide real-time monitoring capabilities, assist in decision-making, and ensure data accuracy, reliability, and consistency.
The rapid digitalization of clinical trials across the globe is one of the primary factors propelling the market growth. EDC systems are widely used to automate various clinical trial operations, such as data collection, storage, monitoring, and analysis, which, in turn, accelerate the process, provide transparency, prevent errors, and improve overall efficiency. In addition to this, the growing demand for new treatments and therapeutics due to the increasing prevalence of chronic diseases, such as diabetes, hypertension, Alzheimer's disease, multiple sclerosis, and cardiovascular diseases (CVDs), are acting as another growth-inducing factor. Furthermore, the rising adoption of the cloud-based system, which is cost-effective, user-friendly, scalable, highly secure, and offers real-time access to data, is providing an impetus to the market growth. Additionally, the introduction of mobile-EDC, which utilize smartphones or tablets as a convenient and cost-effective way to collect patients' data, thus improving engagement, increasing compliance, and reducing the risk of errors, is favoring the market growth. Apart from this, the integration of machine learning (ML) and artificial intelligence (AI) to improve data analysis, enable faster decision-making, and identify patterns, trends, and anomalies is positively influencing the market growth. Moreover, the implementation of stringent government regulations regarding the safety and integrity of clinical trial data is facilitating the demand for advanced data management and reporting systems, such as EDC, which aids in ensuring greater compliance with the authorities. Other factors, including increasing demand for personalized medicines, extensive research and development (R&D) activities, and the growing focus on patient-centric clinical trials, are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global electronic data capture (EDC) systems market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on delivery mode, component, development phase, and end user.
The report has provided a detailed breakup and analysis of the electronic data capture (EDC) systems market based on the delivery mode. This includes on-premise and web & cloud-based. According to the report, web & cloud-based represented the largest segment.
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the component has also been provided in the report. This includes software and services. According to the report, services accounted for the largest market share.
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the development phase has also been provided in the report. This includes phase I, phase II, phase III, and phase IV. According to the report, phase III accounted for the largest market share.
A detailed breakup and analysis of the electronic data capture (EDC) systems market based on the end user has also been provided in the report. This includes hospitals/healthcare providers, CROs, pharmaceutical and biotechnology firms, medical device firms, and others. According to the report, CROs accounted for the largest market share.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for electronic data capture (EDC) systems. Some of the factors driving the North America electronic data capture (EDC) systems market included the rising prevalence of chronic diseases, increasing government initiatives, and rapid technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global electronic data capture (EDC) systems market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Anju Software Inc., Calyx, Clario, Datatrak Int, Medidata Solutions Inc., OpenClinica, LLC, Oracle Corporation, Veeva Systems, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.